Rezafungin treatment in mouse models of invasive candidiasis and aspergillosis: Insights on the PK/PD pharmacometrics of rezafungin efficacy

Rezafungin acetate is a novel echinocandin in clinical development for prevention and treatment of invasive fungal infections. Rezafungin is differentiated by a pharmacokinetic/pharmacodynamic (PK/PD) profile that includes a long half‐life allowing once‐weekly administration, front‐loaded plasma dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Miesel, Lynn, Lin, Kun‐Yuan, Ong, Voon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864408/
https://www.ncbi.nlm.nih.gov/pubmed/31763045
http://dx.doi.org/10.1002/prp2.546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864408/
https://www.ncbi.nlm.nih.gov/pubmed/31763045
http://dx.doi.org/10.1002/prp2.546

Ejemplares similares